Novo Nordisk A/S ADR buy BMO Capital Markets
Start price
12.04.24
/
50%
€119.50
Target price
12.04.25
€153.17
Performance (%)
-0.84%
Price
29.04.24
€118.50
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets for Novo Nordisk A/S ADR is nearly unchanged. This prediction currently runs until 12.04.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Novo Nordisk A/S ADR | 0.424% |
| iShares Core DAX® | 0.961% |
| iShares Nasdaq 100 | 2.626% |
| iShares Nikkei 225® | 0.217% |
| iShares S&P 500 | 1.540% |
Comments by BMO_Capital_Markets for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $163.00 price target on the stock.
Ratings data for NVO provided by MarketBeat